Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 04, 2019 09:15 ET | Source: Adhera Therapeutics, Inc.

Adhera Therapeutics Appoints Nancy Phelan as Chief Executive Officer

RESEARCH TRIANGLE PARK, NC, April 04, 2019 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCQB: ATRX), a specialty pharmaceutical company leveraging technology to commercialize unique therapies and...
November 20, 2018 19:08 ET | Source: Adhera Therapeutics, Inc.

Adhera Therapeutics Provides Third Quarter 2018 Financial Results and Business Update

Research Triangle Park, NC, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCQB: ATRX), an emerging specialty pharmaceutical company commercializing therapies that leverage its...
October 09, 2018 08:00 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces Name Change to Adhera Therapeutics to More Closely Reflect the Mission of Improving Patient Outcomes

Research Triangle Park, NC, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of...
September 24, 2018 08:00 ET | Source: Marina Biotech, Inc.

Marina Biotech Appoints Eric Teague as Chief Financial Officer

Research Triangle Park, NC, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of...
June 20, 2018 11:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Appoints Robert Moscato to Chief Executive Officer

City of Industry, CA, June 20, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of innovative...
February 27, 2018 10:15 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces a New Publication on Prestalia®

City of Industry, CA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
January 16, 2018 08:40 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces Agreement for Drug Development and Licensing with Autotelic Bio

City of Industry, CA, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
November 27, 2017 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Appoints Isaac Blech to its Board of Directors

City of Industry, CA , Nov. 27, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
October 19, 2017 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Appoints Chief Legal Officer to Support Legal, Transactional and Intellectual Property Portfolio Initiatives

City of Industry, CA, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
October 05, 2017 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Appoints Amit Shah as Chief Financial Officer

City of Industry, CA, Oct. 05, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...